NTRB: Total Utang marang Modal Nutriband Inc.

Nutriband Inc. - logo grafis emiten NTRB

The price history of the separate_debt_total_eq metric for Nutriband Inc. (NTRB) is 0.04. The company's business is independent of economic cycles, as the production of patches for opioid addiction relies on FDA decisions. Revenues are based on the licensing of unique patents for transdermal substance delivery. Additionally, the enterprise minimizes environmental impact by implementing medical waste recycling and biodegradable packaging.

Nutriband Inc (NTRB): Rasio Kabeh Utang marang Dana Pribadi saka 04.07.2022 nganti 31.10.2026

Rincian metrik lan analitis perusahaan Nutriband (NTRB)

- rega lan prakiraan konsensus rega:
Bagan rega Nutriband Inc|NTRB - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar Nutriband|NTRB - Nilai Perusahaan
- indikator kapitalisasi buku:
Aset Bersih saben Siji Saham Nutriband|NTRB - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku nutriband.com|NTRB - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Utang marang Ekuitas Nutriband Inc.|NTRB - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Nutriband Inc|NTRB - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Nutriband|NTRB - Kewajiban jangka dawa|Utang jangka cendhak perusahaan Nutriband|Likuiditas cepet nutriband.com
- data bathi resik lan rasio valuasi:
NTRB - Bathi pungkasan
Pambiji fundamental perusahaan:Nutriband Inc., NTRB
Barang utama Nutriband Corp

For Nutriband Inc. (NTRB), the balance between debt and equity determines the funding stability for aggressive R&D in transdermal drug delivery systems. By analyzing changes in the total debt-to-equity ratio, investors assess the degree of leverage within the asset structure, allowing them to differentiate genuine financial recovery from a temporary reduction in debt load amid a liquidity shortage.

Karo sapa Nutriband Inc. saingan

Utang marang Ekuitas Indivior|Rasio Utang marang Ekuitas COLL (Collegium Pharma)|Total Utang marang Modal CRON|Total Utang marang Modal Canopy Growth Corp. (CGC)|Utang marang Ekuitas High Tide Inc. HITI|Rasio Kabeh Utang marang Dana Pribadi ACB|Achieve Life Sciences, Inc. - Total Utang marang Modal|Skye Bioscience Inc. (SKYE) - Rasio Total Utang marang Ekuitas|Anebulo (ANEB) - Utang marang Ekuitas|Utang marang Modal InterCure (INCR)|Rasio Total Utang marang Ekuitas NSRX|IGC: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal MIRA|FLGC: Utang Agregat marang Ekuitas|Total Utang marang Modal IMCC (IM Cannabis)|Total Utang marang Modal Adial Pharmaceuticals Inc. ADIL|ARTL - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ENSC (Ensysce Biosciences)|titanpharm.com (TTNP) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Greenlane Holdings, Inc.|Utang marang Ekuitas InMed Pharma|Rasio Utang marang Ekuitas AKAN (Akanda Inc)|Rasio Total Utang marang Ekuitas ENVB (Enveric Biosciences)|Total Utang marang Modal brightgreen.us (BGXX)|Hempacco Co., Inc. - Rasio Total Utang marang Ekuitas